Evotec SE (EVO) Operating Income (2020 - 2025)
Evotec SE's (EVO) quarterly Operating Income came in at $44000.8 in Q4 2025, up 635.29% year-on-year from $5984.1 in Q4 2024, and up 184.58% quarter-over-quarter from -$52025.3 in Q3 2025.
Evotec SE (EVO) Operating Income (2020 - 2025) Analysis & Trends
Evotec SE has disclosed Operating Income across 6 years of filings, most recently posting $44000.8 for Q4 2025.
- Operating Income for Q4 2025 came in at $44000.8, up 635.29% year-over-year; the trailing twelve-month figure through Dec 2025 was -$31135.4 (up 35.85% YoY), and the FY2025 annual result was -$86721.2, down 56850.47% from the prior year.
- Operating Income came in at $44000.8 for Q4 2025 at Evotec SE, up from -$52025.3 in the prior quarter.
- In the past five years, Operating Income ranged from a high of $44000.8 in Q4 2025 to a low of -$52025.3 in Q3 2025.
- The 5-year median for Operating Income is $1851.0 (2021), against an average of -$2824.3.
- Across the five-year window, Operating Income surged 51416.13% in 2021 and slumped 882.27% in 2023, its largest moves.
- Evotec SE's Operating Income stood at $29803.9 in 2021, then plunged by 157.63% to -$17176.9 in 2022, then tumbled by 125.25% to -$38690.8 in 2023, then surged by 115.47% to $5984.1 in 2024, then surged by 635.29% to $44000.8 in 2025.
- The last three Operating Income figures came in at $44000.8 (Q4 2025), -$52025.3 (Q3 2025), and $5984.1 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 14.03 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 193.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -48.28 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -78.32 Mn |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44,000.84 |
| Sep 30, 2025 | -52,025.29 |
| Dec 31, 2024 | 5,984.13 |
| Sep 30, 2024 | -29,095.13 |
| Dec 31, 2023 | -38,690.80 |
| Sep 30, 2023 | 13,266.65 |
| Jun 30, 2023 | -39,514.89 |
| Dec 31, 2022 | -17,176.88 |
| Sep 30, 2022 | 13,640.94 |
| Jun 30, 2022 | -4,022.80 |
| Mar 31, 2022 | 519.64 |
| Dec 31, 2021 | 29,803.88 |
| Sep 30, 2021 | 20,918.20 |
| Jun 30, 2021 | 1,850.97 |
| Mar 31, 2021 | 8,175.87 |
| Dec 31, 2020 | 57.85 |
| Sep 30, 2020 | 19,120.26 |